Enhabit, Inc. (NYSE:EHAB) Receives $8.75 Average Price Target from Brokerages

Shares of Enhabit, Inc. (NYSE:EHAB) have earned a consensus recommendation of “Hold” from the six research firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $8.75.

Several equities analysts recently issued reports on the company. Leerink Partners restated a “market perform” rating and set a $8.00 price target (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group raised shares of Enhabit from a “hold” rating to a “buy” rating and lifted their target price for the stock from $8.25 to $9.50 in a research note on Monday, December 9th.

Insider Buying and Selling at Enhabit

In related news, Director Jeffrey Bolton acquired 4,000 shares of Enhabit stock in a transaction on Thursday, December 12th. The shares were acquired at an average cost of $8.69 per share, with a total value of $34,760.00. Following the transaction, the director now owns 98,144 shares in the company, valued at $852,871.36. This trade represents a 4.25 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Stuart M. Mcguigan bought 15,000 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was bought at an average cost of $8.81 per share, with a total value of $132,150.00. Following the completion of the transaction, the director now owns 46,810 shares in the company, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. AREX Capital Management LP boosted its position in shares of Enhabit by 2.5% during the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock valued at $22,056,000 after purchasing an additional 59,353 shares in the last quarter. Systematic Financial Management LP boosted its holdings in shares of Enhabit by 12.2% during the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after buying an additional 199,235 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Enhabit by 1.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company’s stock valued at $15,669,000 after buying an additional 26,753 shares in the last quarter. Paradice Investment Management LLC grew its position in shares of Enhabit by 0.7% in the 2nd quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company’s stock worth $13,603,000 after buying an additional 11,128 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Enhabit by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company’s stock worth $8,987,000 after acquiring an additional 10,538 shares in the last quarter.

Enhabit Price Performance

Shares of Enhabit stock opened at $8.53 on Friday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit has a 52-week low of $6.85 and a 52-week high of $11.74. The company has a fifty day moving average of $7.59 and a 200-day moving average of $8.30. The stock has a market capitalization of $428.92 million, a price-to-earnings ratio of -3.68 and a beta of 1.89.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same quarter in the previous year, the company earned $0.03 earnings per share. Equities research analysts expect that Enhabit will post 0.22 EPS for the current year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.